These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28910948)

  • 1. [Risk on bias assessment: (2) Revised Cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0)].
    Yang ZR; Sun F; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1285-1291. PubMed ID: 28910948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bias risk assessment: (3) Revised Cochrane bias risk assessment tool for individual randomized, cross-over trials (RoB2.0)].
    Wu SS; Sun F; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Oct; 38(10):1436-1440. PubMed ID: 29060995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk related to bias assessment: (4) Revised Cochrane Risk of Bias Tool for cluster-randomized control trials (RoB2.0)].
    Lyu XZ; Sun F; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):240-244. PubMed ID: 29495213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence of systematic reviews to Cochrane RoB2 guidance was frequently poor: a meta epidemiological study.
    Minozzi S; Gonzalez-Lorenzo M; Cinquini M; Berardinelli D; Cagnazzo C; Ciardullo S; De Nardi P; Gammone M; Iovino P; Lando A; Rissone M; Simeone G; Stracuzzi M; Venezia G; Moja L; Costantino G;
    J Clin Epidemiol; 2022 Dec; 152():47-55. PubMed ID: 36156301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction.
    Minozzi S; Dwan K; Borrelli F; Filippini G
    J Clin Epidemiol; 2022 Jan; 141():99-105. PubMed ID: 34537386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of the Risk of Bias 2 Tool].
    Lee LL
    Hu Li Za Zhi; 2021 Apr; 68(2):85-91. PubMed ID: 33792022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Series of risk of bias assessment (5): Risk Of Bias In Non-randomized Studies-of Interventions (ROBINS-I)].
    Sun F; Gao L; Yang ZR; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Mar; 39(3):374-381. PubMed ID: 29609257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies.
    Barker TH; Habibi N; Aromataris E; Stone JC; Leonardi-Bee J; Sears K; Hasanoff S; Klugar M; Tufanaru C; Moola S; Munn Z
    JBI Evid Synth; 2024 Mar; 22(3):378-388. PubMed ID: 38287725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review.
    Crocker TF; Lam N; Jordão M; Brundle C; Prescott M; Forster A; Ensor J; Gladman J; Clegg A
    J Clin Epidemiol; 2023 Sep; 161():39-45. PubMed ID: 37364620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of methodologic quality of randomized trials of interventional techniques: development of an interventional pain management specific instrument.
    Manchikanti L; Hirsch JA; Cohen SP; Heavner JE; Falco FJ; Diwan S; Boswell MV; Candido KD; Onyewu CO; Zhu J; Sehgal N; Kaye AD; Benyamin RM; Helm S; Singh V; Datta S; Abdi S; Christo PJ; Hameed H; Hameed M; Vallejo R; Pampati V; Racz GB; Raj PP
    Pain Physician; 2014; 17(3):E263-90. PubMed ID: 24850111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROBINS-1: A tool for asssessing risk of bias in non-randomised studies of interventions.
    Hinneburg I
    Med Monatsschr Pharm; 2017 Apr; 40(4):175-7. PubMed ID: 29952172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of bias in randomized trials of pharmacological interventions in children and adults.
    Sinha YK; Craig JC; Sureshkumar P; Hayen A; Brien JA
    J Pediatr; 2014 Aug; 165(2):367-371.e1. PubMed ID: 24814415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a study protocol.
    da Costa BR; Resta NM; Beckett B; Israel-Stahre N; Diaz A; Johnston BC; Egger M; Jüni P; Armijo-Olivo S
    Syst Rev; 2014 Dec; 3():144. PubMed ID: 25495124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk of bias assessment of trials in systematic reviews of oral health interventions, 1991-2014: A methodology study.
    Saltaji H; Ospina MB; Armijo-Olivo S; Agarwal S; Cummings GG; Amin M; Flores-Mir C
    J Am Dent Assoc; 2016 Sep; 147(9):720-728.e1. PubMed ID: 27155754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Reporting Randomized Controlled Trials in Five Leading Neurology Journals in 2008 and 2013 Using the Modified "Risk of Bias" Tool.
    Zhai X; Cui J; Wang Y; Qu Z; Mu Q; Li P; Zhang C; Yang M; Chen X; Chen Z; Li M
    World Neurosurg; 2017 Mar; 99():687-694.e7. PubMed ID: 28089838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa.
    Ndounga Diakou LA; Ntoumi F; Ravaud P; Boutron I
    Trials; 2017 Jul; 18(1):291. PubMed ID: 28676066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There were large discrepancies in risk of bias tool judgments when a randomized controlled trial appeared in more than one systematic review.
    Jordan VM; Lensen SF; Farquhar CM
    J Clin Epidemiol; 2017 Jan; 81():72-76. PubMed ID: 27622779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key concepts in clinical epidemiology: addressing and reporting sources of bias in randomized controlled trials.
    Kotz D; West R
    J Clin Epidemiol; 2022 Mar; 143():197-201. PubMed ID: 34571193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automating risk of bias assessment for clinical trials.
    Marshall IJ; Kuiper J; Wallace BC
    IEEE J Biomed Health Inform; 2015 Jul; 19(4):1406-12. PubMed ID: 25966488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.